logo
Target Explores Factory-Direct Shipping Model Used by Temu

Target Explores Factory-Direct Shipping Model Used by Temu

Target Corp. is testing the delivery of products directly to customers' homes from factories, said people familiar with the matter, an effort by the big-box retailer to launch a service similar to the Chinese e-commerce platforms Temu and Shein.
The company is seeking to broaden its range of low-cost offerings through the initiative, said the people, who asked not to be named because the test hasn't been announced. Products would primarily include apparel, household goods and other non-food items, according to the people, who added the effort is in the early stages.
A Target spokeswoman said the company is constantly testing new ways to deliver products and services.
'In all cases, we uphold the high quality, responsible sourcing and sustainability standards that Target is known for and that consumers expect from us,' she said.
ADVERTISEMENT
The Minneapolis-based retailer has struggled to revive sales growth in recent years and is looking for new avenues following choppy store traffic, soft demand and inventory missteps. Target shares are down 28 percent so far this year, while the S&P 500 Index has risen 3.6 percent, raising pressure on management to improve results.
Most online orders from Target and other US retailers get sent to warehouses before going to consumers via truck delivery. By shipping directly from production sites, Target can offer lower prices and potentially increase market share among discounters.
The X factor remains the US government's move to close the so-called de minimis exemption, which for years allowed Shein and Temu to capture market share by shipping orders of less than $800 to US customers duty free. The change has eroded performance at both companies, and could also impact direct-shipping efforts of Target and other retailers.
After years of price increases across the economy, shoppers are spending less on toys, clothes and other discretionary items — Target's core categories. Tariffs are creating new challenges, as are boycotts after the company pulled back on diversity initiatives earlier this year.
Target slashed its full-year sales forecast in May after missing Wall Street expectations for its last quarter. Target executives acknowledged then that they are not hitting the mark.
Major holidays and limited-time design collaborations are bringing shoppers into stores, but the company isn't seeing that momentum every day, executives said. To counter this, the retailer is sharpening its focus on low prices and new products. In recent months, Target has said it's speeding up product development.
Target's competition includes Temu, a unit of PDD Holdings Inc., Shein, Walmart Inc. and Amazon.com Inc., which started a low-cost online storefront called Haul that sells most items for under $20.
By Jaewon Kang
ADVERTISEMENT
Learn more:
Op-Ed | Target's DEI Flip-Flop Came at a Price
Early data indicates Target and Walmart's store traffic has declined since their DEI exit, while Costco's has grown, signalling that we may be entering a new era of consumer boycotts.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Codasip looks to Silicon Creations' PLL to drive RSIC-V Automotive Safety-Critical Core
Codasip looks to Silicon Creations' PLL to drive RSIC-V Automotive Safety-Critical Core

Business Wire

time19 minutes ago

  • Business Wire

Codasip looks to Silicon Creations' PLL to drive RSIC-V Automotive Safety-Critical Core

ATLANTA--(BUSINESS WIRE)-- Silicon Creations, a leading provider of high-performance analog and mixed-signal intellectual property (IP) today announced that its low-area integer PLL has been successfully integrated into Codasip's latest test chip, enabling the evaluation of Codasip's L31AS dual-core lock-step CPU and crypto accelerator IP. The collaboration marks a key milestone in the deployment of robust and efficient clocking solutions for automotive-grade RISC-V systems. Designed for automotive applications, Codasip's L31AS CPU is a safety-critical, high-performance RISC-V core. To meet the stringent clocking requirements of this environment, Codasip selected Silicon Creations' low-area integer PLL for its ultra-small footprint, proven silicon track record, ease of integration, and excellent low-jitter digital clock generation. The integration delivered the precise clocking performance needed while minimizing silicon area and system complexity. 'We are thrilled to support Codasip's innovative RISC-V processor development with our area-optimized digital clocking PLL,' said Randy Caplan, co-founder of Silicon Creations. 'This partnership highlights not only the flexibility of our PLL technology but also how optimized clocking solutions can help accelerate the delivery of automotive-grade, high-performance computing platforms.' Paul Elliott, Senior Security and Safety Architect at Codasip, commented, 'The successful integration of Silicon Creations' PLL into our L31AS dual-core test chip is a significant step for Codasip. As we advance our automotive and embedded system solutions, the reliability and performance of this PLL will play a critical role in supporting our next-generation designs.' With several upcoming projects requiring precise and efficient PLL technology, Codasip's successful test chip evaluation reinforces its commitment to driving innovation in RISC-V-based technologies for the automotive and embedded markets. The collaboration with Silicon Creations demonstrates the importance of strategic IP partnerships in accelerating time-to-market while meeting stringent industry requirements. About Codasip Codasip is a leading provider of customizable processor cores and associated toolchains, specializing in RISC-V-based architectures. The company offers high-performance, energy-efficient solutions for a wide range of applications, including automotive, embedded systems, and IoT. Codasip's flexible and scalable designs meet the growing demands of the semiconductor industry with future-proof solutions. About Silicon Creations Silicon Creations provides world-class silicon intellectual property (IP) for precision and general-purpose timing PLLs, SerDes and high-speed differential I/Os. Silicon Creations' IP is in production from 3 to 180 nanometer process technologies, with 2nm GDS available for deployment. With a complete commitment to customer success, its IP has an excellent record of first silicon to mass production in customer designs. Silicon Creations, founded in 2006, is self-funded and growing. The company has development centers in Atlanta, USA, and Krakow, Poland, and worldwide sales representation. For more information, visit All reference to Silicon Creations trademarks are the property of Silicon Creations, Inc. All other trademarks mentioned herein are the property of their respective owners.

What's driving the action in Amazon's stock, plus our hopes for Disney earnings
What's driving the action in Amazon's stock, plus our hopes for Disney earnings

CNBC

time20 minutes ago

  • CNBC

What's driving the action in Amazon's stock, plus our hopes for Disney earnings

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Tuesday's key moments. 1. U.S. stocks were down Tuesday as Wall Street digested lackluster economic data and new quarterly earnings reports. The ISM services index came in a bit weaker than expected, weighing on investor sentiment. Meanwhile, Palantir's blowout earnings release moved the tech-heavy Nasdaq Composite higher briefly in early trading, but has since lost steam. The biggest losses were seen in the Dow Jones Industrial Average and S & P 500 , which slipped 0.4% and 0.3%, respectively. 2. Club holding Walt Disney reports quarterly earnings on Wednesday. We hope to see continued resilience in the company's theme parks, and will be looking out for profitability in its streaming division. Shares of the entertainment giant are down more than 1% Tuesday — a move that Jim Cramer celebrates ahead of the release. "I wanted it to come down," he said. "This is much better." That's because when a stock is up significantly into earnings, investors are more likely to treat the release as a "sell the news" event. 3. Amazon shares are up over 1% Tuesday following the Big Tech name's post-earnings decline. In fact, between last Friday and Monday's close, the stock dropped roughly 10%. Jim cited investor concerns over Amazon's dominance in its cloud computing business for the weakness as competitors like Alphabet- owned Google and OpenAI grabbed share. We're standing by the stock for now though. "I think it's not as clear cut as people think," Jim said. "I would point out that it has a huge business." The solution, Jim said, is for Amazon to spend more on Nvidia chips in order to improve its crucial cloud computing division. "Could it accelerate? Yes, [but] they have to get away from their own chips where they're viewed as not being as powerful." 4. Stocks covered in Tuesday's rapid fire at the end of the video were: Palantir, Caterpillar , Yum Brands , Pfizer and Marriott International. (Jim Cramer's Charitable Trust is long DIS, AMZN, NVDA. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

Pfizer posts strong earnings despite Trump's new 'up to 250%' tariff threat
Pfizer posts strong earnings despite Trump's new 'up to 250%' tariff threat

Yahoo

time22 minutes ago

  • Yahoo

Pfizer posts strong earnings despite Trump's new 'up to 250%' tariff threat

Pharmaceutical giant Pfizer reported better-than-expected quarterly results on Tuesday and improved its predictions for full-year profits, beating Wall Street expectations. The New York-based company reported second-quarter sales of $14.7 billion (€12.74bn) and earnings per share of $0.51 (€0.44). As of around 16.00 CEST, Pfizer shares were up over 4% at $24.58. "Our business is performing well and I'm pleased with the progress we achieved in the second quarter," chairman and CEO Albert Bourla said in a statement. "We continue to be actively engaged with policymakers as we navigate a complicated and rapidly evolving geopolitical environment while also remaining focused on advancing our business," Bourla continued. This despite several policies announced by the current US administration that could hurt drugmakers. Related Irish exports hit record high with pharmaceuticals showing major boost EU Commission loses on all counts in Pfizergate legal case In May, US President Donald Trump signed an executive order whereby pharmaceutical companies would be compelled to lower prices based on a "Most Favored Nation" policy. The price-slashing scheme seeks to ban drug companies from selling products in the US at prices above those in other developed countries. In Europe, the comparison becomes complex, as a significant portion pharmaceutical costs are covered by national healthcare or insurance systems, lowering prices for consumers. Experts warned at the time that this could slash their US revenues and affect availability. Even so, the president doubled down on his plans, sending letters last week to 17 drugmakers, calling for concrete steps to cut prices by 29 September. That includes agreeing to provide their full portfolio of existing medicines at no higher than European prices to every single Medicaid patient. On Tuesday, in an interview with CNBC, he announced that tariffs for pharmaceuticals and semiconductors would be coming in "next week". 'We'll be putting an initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country," he told CNBC. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store